CDK2 and hepatocellular carcinoma: We performed CDK2 knockdown to rescue the UHRF2 phosphorylation promoted by miR-222-3p inhibitor and observed the changes in proliferation, migration and invasion functions of HBV-positive HCC cells among the NC, positive and rescue groups.